Cumberland Pharmaceuticals Inc. Business Combination, Contingent Consideration, Liability, Current
Cumberland Pharmaceuticals Inc. (CPIX) had Business Combination, Contingent Consideration, Liability, Current of $2.70 million as of 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2022-03-11
- 2021-12-31: Business Combination, Contingent Consideration, Liability, Current $2.70M.
- 2020-12-31: Business Combination, Contingent Consideration, Liability, Current $3.30M.
- 2019-12-31: Business Combination, Contingent Consideration, Liability, Current $2.37M.
- 2018-12-31: Business Combination, Contingent Consideration, Liability, Current $2.29M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2021-12-31 | $2.70M 10-K · filed 2022-03-11 |
| 2020-12-31 | $3.30M 10-K · filed 2021-03-12 |
| 2019-12-31 | $2.37M 8-K · filed 2020-12-10 |
| 2018-12-31 | $2.29M 8-K · filed 2020-12-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |